MARKETING and DISTRIBUTION
AGREEMENTS
We provide full commercialization capabilities based on registration and market authorization, pricing and reimbursement:
- Full distribution capabilities in selected emerging and growth markets or targeted markets in Europe;
- A tailor-made, affordable and flexible fee structure for each country without up-front charges.
Together with our partners, we make a holistic assessment and propose an approach that meets the strategic objectives of our partners in every single market.
Our distribution capabilities allow optimal life cycle management in key emerging and growth markets. Often, a phased and combined approach in which a therapy is initially supplied on a paid access, named patient basis and later gains marketing authorization optimizes patient access, drug potential and market access investments.
Pharmaceutical and biotech companies wishing to join our growing global partnerships portfolio may contact us at info@farmamondo.com.
